In February 2016, BCCRIN was repurposed to help establish BC AHSN, with the BC AHSN Board committed to supporting its mandate.
A report was commissioned for the BC AHSN Board to assess BCCRIN’s current state and to provide recommendations. The recommendations from the Board were to:
- In partnership with key BCCRIN stakeholders, facilitate the development of a vision for BC’s clinical research environment;
- As part of that vision, confirm the role, branding, leadership, and resources for BCCRIN as a clinical research unit parallel to the BC SUPPORT Unit within BC AHSN.
In March 2017, BC AHSN/ BC SUPPORT Unit hosted a strategic planning workshop with key stakeholders to collectively develop a vision and offer recommendations to the BC AHSN Board for supporting a thriving clinical research environment that builds on the legacy of BCCRIN.
Under the new name of Clinical Trials BC, a project to transition clinical research support functions into BC AHSN was initiated, overseen by a project steering committee and implemented by a working group.
In February 2018, the BC AHSN Board of Directors confirmed a two-year budget to support Clinical Trials BC’s five strategic priorities. The transition project is now complete and Clinical Trials BC is operationalizing the strategic priorities as approved by the Board.
Transition Project Steering Committee
Deirdre Rogers, Clinical Trials BC